The measles virus (MV) haemagglutinin (HA) is a class 2 glycoprotein by means of which the virus particle attaches to the host cell receptor. We have previously expressed this glycoprotein as a vaccinia recombinant virus and have shown that the HA glycoprotein synthesized is indistinguishable from that coded by MV. In the present study, we report that in RK13 cells a soluble form (sHA) of the HA is secreted into the medium. We show by SDS-PAGE and sucrose density gradient centrifugation that the sHA is a dimer and is smaller than the cell-associated form. Using a variety of inhibitors the production of sHA was shown to be a late event, probably occurring at the membrane; only fully glycosylated molecules were found in sHA. Finally, we demonstrate that sHA retains its antigenicity with conformation-dependent MAbs and its receptor recognition function. We conclude that sHA is a valuable tool for use in studies of the structure and function of the MV HA glycoprotein.
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The measles virus (MV) haemagglutinin (HA) is a class 2 glycoprotein by means of which the virus particle attaches to the host cell receptor. We have previously expressed this glycoprotein as a vaccinia recombinant virus and have shown that the HA glycoprotein synthesized is indistinguishable from that coded by MV. In the present study, we report that in RK13 cells a soluble form (sHA) of the HA is secreted into the medium. We show by SDS-PAGE and sucrose density gradient centrifugation that the sHA is a dimer and is smaller than the cell-associated form. Using a variety of inhibitors the production of sHA was shown to be a late event, probably occurring at the membrane; only fully glycosylated molecules were found in sHA. Finally, we demonstrate that sHA retains its antigenicity with conformation-dependent MAbs and its receptor recognition function. We conclude that sHA is a valuable tool for use in studies of the structure and function of the MV HA glycoprotein.
Infection of cells by measles virus (MV), a member of the paramyxovirus group, is restricted to host cells that permit envelope binding and fusion. Two MV glycoproteins are involved in this process: the haemagglutinin (HA) and the fusion (F) proteins, which are respectively responsible for virus attachment and entry. The HA of MV is a class 2 membrane glycoprotein. After synthesis, it forms disulphide-linked dimers and the mature HA is likely to be a homotetramer (Hardwick & Bussel, 1978; Malvoisin & Wild, 1993) .
The cellular receptor involved in attachment of MV to the cell surface has recently been identified as CD46 (DSrig et al., 1993; Naniche et al., 1993) . The CD46 molecule or membrane cofactor protein (MCP) is a membrane-bound complement regulatory protein present in most human cells (for a review see Liszewski et al., 1991) . However, recently another cell-membrane protein termed moesin has been found to act as a receptor for measles virus (Dunster et al., 1994) . The availability of a soluble form of HA may be a useful tool for structure/ function studies of the HA and its interaction with cellular receptors.
In the paramyxovirus group, soluble forms of HA have been obtained either by protein initiation from within the transmembrane region, by protease treatment of the detergent-solubilized HA of virions or by expression of recombinant HA lacking the membrane anchor in tissue culture cells (Thompson et al., 1988; McGinnes et al., 1993; Mirza et al., 1993) . In the present study, we showed that a soluble form of HA was released from the surface of RK13 cells infected with a vaccinia recombinant virus expressing the MV HA (VV-HA) protein (DriIlien et al., 1988) . We have further characterized the soluble HA and shown that it retains antigenicity and receptor-binding activities.
RK13, HeLa and Vero cells were infected with VV-HA (0-2 p.f.u./cell) and labelled with Tran3~S (70 % [35S]methionine, 15% pS]cysteine; ICN). The 3sS-labelled HA (a~S-HA) was immunoprecipitated from the cells and medium with an anti-HA monoclonal antibody, MAb 55 (Giraudon & Wild, 1985) and analysed by SDS PAGE (Fig. 1 a) . A secreted form (sHA) was not found in HeLa or Veto cells infected with VV-HA (not shown), but in RK13 cells a protein of 140K (nonreduced) was observed which, after reduction with 2-mercaptoethanol, migrated as the monomeric 70K form. The cell-associated form had an Mr of 80K. By measuring the radioactivity of the corresponding bands in the gel with an automatic TLC-linear analyser, it was found that up to 5% of the HA synthesized was released into the medium. To examine the oligomeric nature of the sHA, 3~S-sHA was centrifuged on 5-25% sucrose gradients and analysed by immunoprecipitation and SDS-PAGE. The major forms of the glycoproteins centrifuged to the position of a dimer (fraction 6) (Fig. l b) . Using the irreversible cross-linking agent EGS we failed to stabilize higher oligomeric forms (not shown).
The MV HA has five potential N-glycosylation sites of which four have been shown to be used; these are grouped between amino acids 168 and 215 ( were infected with VV-HA and 16 h later labelled for 6 h with Tran3~S (150~tCi/ml; ICN) in methionine/cysteine-deficient medium. The medium (2 ml) was added 30 min before addition of radioactivity. (a) After incubation, z~S-HA [cleared RIPA (radioimmunoprecipitation assay) lysate] or zSS-sHA (supernatant) were immunoprecipitated by incubation with anti-HA MAb 55 overnight at 4 °C. After adsorption onto Sepharose-protein A (Pharmacia), the complexes were washed three times in RIPA buffer (1% Triton X-100, 0.6 M-KC1, 0.15 M-NaC1, I0 mM-Tri~HCI, pH 7-4), once in TNE (0.15 M-NaC1, 1 mM-EDTA, 0-05 M-Tris-HC1, pH 7-2) and then denatured in sample buffer by boiling for 2 min with or without 1% 2-mercaptoethanol (2-ME). The samples were then analysed on SD~7 % polyacrylamide gels (Laemmli, 1970) . Lane 1, immnnoprecipitation of medium; lane 2, immunoprecipitation of cells. (b) Sucrose gradient analysis of 3~S-sHA. Culture supernatants containing 35S-sHA (300 ~tl) were loaded onto 5 25% sucrose gradients (in 0-1% octylglucoside/PBS, pH 7.4) and centrifuged for 16h at 35000r.p.m. in a SW50.1 rotor at 5°C. Thyroglobulin (669K), ferritin (440K), catalase (232K), y-globulin (158K) and albumin (67K) were used as standards to calibrate the Rose, 1993; Hu et al., 1994) . The size of the MV sHA indicates that all the N-glycosylation sites are conserved. During glycoprotein biosynthesis, asparagine-linked oligosaccharides are susceptible to digestion by endo H (endoglycosidase H) until converted from high mannose to the hybrid or complex type by the action of enzymes in the medial-and trans-Golgi cisternal compartments (for a review see Kornfeld & Kornfeld, 1985) . To study the carbohydrate structure of sHA, the secreted z~S-sHA and the cell-bound 35S-HA were immunoprecipitated with the anti-HA MAb and the proteins were treated with endo H (Sigma). As shown in Fig. 2 (a), digestion of sHA with endo H did not modify its electrophoretic migration, indicating that it contained predominantly endo-H-resistant terminally glycosylated oligosaccharide chains. In contrast, digestion of the cell-bound HA with endo H altered the mobility of a fraction of the protein (Fig. 2b) . The H A that was immunoprecipitated on the cell surface and digested with endo H also contained both endo-H-resistant (complex-type N-linked oligosaccharides) and endo-H-sensitive (high mannose or hybrid-type oligosaccharides) molecules (Fig. 2c) . The presence of an almost exclusively endo-H-resistant sHA in the supernatant may indicate that only the HAbearing complex-type N-glycans are sensitive to the protease. Susceptibility of glycoproteins to protease has been reported to be linked to their N-glycan composition (Olden et al., 1985; Malvoisin & Wild, 1994) . To remove all the N-linked oligosaccharides, sHA was treated with PNGase (N-glycosidase F; Boehringer Mannheim). The digested sHA protein analysed under reducing conditions migrated with an apparent M r of 59K (Fig. 2d) . The same mass difference ( t / K ) was obtained when the cell-associated HA was digested with PNGase, suggesting that sHA contained all the glycosylation sites (Fig. 2 c) . Our previous studies have shown that H A synthesized in the presence of tunicamycin, an inhibitor of N-glycosylation, migrates under reducing conditions with an apparent M r of 69K (Malvoisin & Wild, 1994) .
There are now available a number of inhibitors which block glycoprotein synthesis at different points during transport from the endoplasmic reticulum (ER) to the plasma membrane. We have used these inhibitors to determine at which point sHA is formed. RK13 cells were infected with V V -H A and incubated in the presence of brefeldin A (BFA), tunicamycin, monensin or nigericin (all from Sigma) (Fig. 3) . BFA causes rapid redistribution of Golgi proteins into the ER, probably by blocking . Immunoprecipitated glycoproteins were released from protein A-Sepharose beads by boiling and digested with endo H as described previously (Fenouillet et al., 1989) . Lanes 1 and 2 correspond to undigested and digested proteins respectively. The lane labelled M contains M r markers (200K, 97K and 69K) . (c) asS-HA was immunoprecipitated on the cell surface with MAb 55 as previously described (Malvoisin & Wild, 1993) . Immunoprecipitated proteins were digested with endo H or PNGase as described previously (Fenouillet et al., 1989) . Lane 1, undigested proteins; lanes 2 and 3, digested proteins. (d) aaS-sHA was digested with PNGase and then immunoprecipitated with MAb 55. Lanes 1 and 2 correspond to undigested proteins and digested proteins respectively. The positions of monomeric (1 x ) and dimeric (2 x ) HA are indicated• In (c) samples were analysed on a 10 % polyacrylamide gel under reducing conditions• anteretrograde but not retrograde membrane traffic (Lippincott-Schwartz et al., 1989) . Enzymes normally residing in the Golgi complex are relocated to the ER, and these can process both resident ER proteins and newly synthesized proteins now retained in this organelle (Doms et al., 1989; Lippincott-Schwartz et al., 1989) . In the presence of BFA, HA was expressed intracellularly bul its transport to the membrane was blocked. No secretion of aSS-sHA was observed, suggesting that the proteolytic cleavage of HA occurs after the Golgi (Fig.  3 a, right-hand panels, lanes 2 and 3). Tunicamycin, an inhibitor of N-glycosylation, is known to affect the intracellular transport and folding of proteins (Gallagher et al., 1992; Tifft et al., 1992; Li et al., 1993) . It inhibited detectable HA synthesis as measured with an anti-HA MAb (Fig. 3a, right-hand panel, lanes 4 and 5). The secretion of aSS-sHA was decreased but not totally inhibited by monensin, a carboxylic ionophore reported to block transport between the medial-and trans-Golgi compartments (Fig.  3a , right-hand panels, lanes 6 and 7) (Griffiths et al., 1983; Tartakoff, 1983) . We also evaluated the effect of nigericin, another carboxylic ionophore (Tartakoff & Vassalli, 1977) . At high concentrations of nigericin, asSsHA secretion was greatly reduced (Fig. 4a, right- expression at the cell surface was unaffected by monensin.
In the presence of nigericin, the cell-surface expression of HA was greatly inhibited (Fig. 3b, lane 1) . The antigenicity of sHA was determined using a panel of specific anti-HA MAbs. As shown in Fig. 4(a, b) , all the MAbs used immunoprecipitated the cell-associated HA and sHA with equal efficiency. In Fig. 4(a) , the bands migrating slower than sHA represent aggregates of full-length HA (E. Malvoisin, unpublished data).
HA is responsible for attachment of the virus to its host cell. However, it was important to establish whether or not sHA retained this property. To examine the ability of sHA to attach to CD46 we used HeLa cells as CD46* and RK13 as CD46-cells, aSS-sHA was added to HeLa and RK13 cells at 5 °C and incubated for 24 h. The cells were then washed with PBS and aSS-sHA bound to the receptor was immunoprecipitated from the cell lysate with anti-HA MAbs. As shown in Fig. 5(a, b) , aSS-sHA was immunoprecipitated with all the anti-HA MAbs from HeLa cells but not from RK13 cells.
We then evaluated the ability of anti-CD46 MAbs to co-precipitate sHA and the CD46 receptor. In order to demonstrate that the anti-CD46 MAbs used were able to immunoprecipitate CD46, HeLa cells were labelled with Tran35S and the cell lysate containing asS-CD46 was analysed by immunoprecipitation and SDS-PAGE.
Immunoprecipitates analysed under non-reducing conditions with either of two anti-CD46 MAbs (29 or E4.3) identified the characteristic double band at 57/67K which has been demonstrated previously (Naniche et al., 1993) (Fig. 5c, d) . In reducing conditions, the doublet migrated slightly more slowly. The band with an apparent M r of 46K is due to a non-specific reaction with an unidentified protein of cellular origin (Fig. 5 c) .
To study the co-immunoprecipitation of the sHA-CD46 complex, 3SS-sHA was added to HeLa and RK13 cells at 5 °C for 24 h. The cells were then washed with PBS and 35S-sHA bound to the receptor was immunoprecipitated from the cell lysate with anti-CD46 MAbs. As shown in Fig. 5(e) , lane 2, MAb E4.3 was able to co-precipitate an sHA-CD46 complex. 35S-sHA was not immunoprecipitated from RK13 cells whefi using the same anti-CD46 (Fig. 5 e, lane 3) . MAb 29 was unable to co-precipitate an sHA-CD46 complex (not shown).
In this report, we have shown that a soluble form of HA was secreted into the culture medium of RK13 cells infected with a vaccinia virus recombinant expressing the MV HA glycoprotein. This form migrated in nonreducing SDS-PAGE faster than the cell-associated homodimeric HA and sedimented in sucrose gradients as a dimer. The sHA did not form detectable tetramers. These observations suggest that the oligomerization domain of the MV HA glycoprotein may be associated with the transmembrane domain. The presence of all Nglycosylation sites suggests that the proteolytic cleavage occurs close to the cell membrane. In BFA-treated cells, no truncated form of HA was seen intracellularly, suggesting that a mechanism involving an alternative initiation site is unlikely to be the origin of sHA.
Monensin usually blocks or slows down protein transport through the Golgi stack and affects protein glycosylation, but did not block the transport of HA expressed by the vaccinia virus recombinant. Similar observations have been made for simian immunodeficiency virus gpl20 expressed by a recombinant vaccinia virus and in MV (Edmonston strain) expression in HeLa cells (Ogura et al., 1991; Spies & Compans, 1993) .
The apparent size of HA after SDS-PAGE was slightly larger with monensin and nigericin treatments and smaller with BFA. These compounds are known to modify N-linked oligosaccharide synthesis (Sampath et al., 1992) . The secretion of 3~S-sHA decreased in the presence of monensin. Modification of N-linked oligosaccharide composition may change the conformation of the molecule or the accessibility of the cleavage site to the protease and thus modify the susceptibility to proteolysis. In agreement with this, only sHA bearing complex-type N-linked oligosaccharides was secreted. This suggests that proteolytic cleavage occurs at the cell surface. Oligomerization was unaffected by the addition of BFA, which is consistent with this step occurring in the ER.
The soluble form of HA released from RK13 cells infected with VV-HA reacted with several conformationdependent MAbs and retained its ability to bind to the receptor, suggesting that it is conformationally similar to the complete molecule. It was possible to precipitate sHA bound to cellular receptors with anti-HA MAbs. All the MAbs used were neutralizing, suggesting that sites involved in neutralization may be located outside of the receptor-binding regions. Both anti-CD46 MAbs (29 and E4.3) were able to precipitate CD46 from HeLa cells, but only MAb E4.3 co-precipitated the HA. We obtained the same results with a vaccinia virus recombinant-expressed CD46, which indicates that these MAbs recognize different epitopes (E. Malvoisin, unpublished) .
In conclusion, we have shown that the soluble form of HA retained its receptor-recognition function and thus it will be a valuable tool to study HA/receptor interactions and define the regions of CD46 involved in binding the haemagglutinin. 
